Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kaiwen Jiang
Institution:
Guilin Medical University
Observed institutions:
Shenyang Pharmaceutical University,
Guilin Medical University
ORCID:
0009-0007-8993-3569
Observed ORCID:
0009-0007-8993-3569
OpenAlex ID:
A5060024006
The Biological Fate of Pharmaceutical Excipient β-Cyclodextrin: Pharmacokinetics, Tissue Distribution, Excretion, and Metabolism of β-Cyclodextrin in Rats
2022
·
Kunqian Mu
, Kaiwen Jiang
, et al.
·
Molecules
·
33
PDF
Nephrotoxicity of Immune Checkpoint Inhibitors: A Disproportionality Analysis from 2013 to 2020
2021
·
Jiaming Qu
, Yanming Ding
, et al.
·
The Tohoku Journal of Experimental Medicine
·
13
PDF
The Material Basis and Mechanism of Xuefu Zhuyu Decoction in Treating Stable Angina Pectoris and Unstable Angina Pectoris
2022
·
Guanpeng Qi
, Kaiwen Jiang
, et al.
·
Evidence-based Complementary and Alternative Medicine
·
9
PDF
Efficacy and Safety Analysis of Transarterial Chemoembolization Combined with Sintilimab Plus Bevacizumab Biosimilar in the Treatment of Unresectable Hepatocellular Carcinoma
2025
·
Huixia Qin
, Kaiwen Jiang
, et al.
·
Journal of Hepatocellular Carcinoma
·
6
PDF
Comparing of Efficacy and Safety Between Sintilimab Plus IBI305 and PD ‐1 Inhibitor Plus TKIs in Combination of TACE for uHCC
2026
·
Houxiang Ya
, Kai Wang
, et al.
·
Liver International
·
2
Whether Adjuvant TACE Plus TKI Therapy is More Effective Than TACE Alone in HCC Patients at High Risks of Recurrence Following Radical Hepatectomy
2025
·
Yaohua Li
, Kai Wang
, et al.
·
Journal of Hepatocellular Carcinoma
·
1
Prognostic Value of the SEA Score in Double-Negative DCP/AFP Unresectable HCC with Triple Therapy
2026
·
Hesheng Lin
, Fulin Ran
, et al.
·
Journal of Hepatocellular Carcinoma
PDF
Show more works
View as search
Works count:
7
Citation count:
64
H-index:
4
I10-index:
2
Year
Topic
Type